Additionally, a previous study suggested that the overexpression of SMAD7 may suppress tumour progression by antagonizing TGF-β [73], while the high expression and low methylation of SMAD7 in our EIC were associated with poor prognosis for LUSC. Here, SMAD7 is linked to neoplasm.